Skip to main content
TGTX
NASDAQ Life Sciences

TG Therapeutics Q2 BRIUMVI Revenue Hits $228M, Raises 2026 Guidance to ~$950M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$51.3
Mkt Cap
$7.965B
52W Low
$25.28
52W High
$59.3
52W Position info
103% above low
Off High info
13% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

TGTX has more than doubled off its 52-week low of $25.28.

Summary

TG Therapeutics delivered Q2 BRIUMVI U.S. revenue of $228M, a 64% jump year-over-year, and lifted its full-year 2026 total revenue guidance to approximately $950M — above the $885M–$900M range set in May. The beat and raise signal accelerating commercial traction for its lead multiple sclerosis drug. This follows the May guidance hike and positive Phase 3 ENHANCE data, reinforcing the growth narrative. With a $7.96B market cap, the raised outlook materially shifts the revenue trajectory. Next catalyst: potential subcutaneous BRIUMVI data readouts later this year.

At the time of this announcement, TGTX was trading at $51.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8B. The 52-week trading range was $25.28 to $59.30. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

TGTX - Latest Insights

TGTX
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $63.54
Real-time Price: $63.21 info
Change: -$0.3272 (-0.51%) info
Market Cap: $9.574B info
TGTX
Nov 09, 2026, 4:33 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $63.55
Real-time Price: $63.21 info
Change: -$0.340 (-0.54%) info
Market Cap: $9.574B info
TGTX
Nov 09, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $63.00
Real-time Price: $63.21 info
Change: +$0.210 (+0.33%) info
Market Cap: $9.574B info
TGTX
Nov 09, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $58.11
Real-time Price: $63.21 info
Change: +$5.10 (+9%) info
Market Cap: $9.574B info
TGTX
Oct 23, 2026, 11:03 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $52.44
Real-time Price: $63.21 info
Change: +$10.77 (+21%) info
Market Cap: $9.574B info